Introduction
PT Kimia Farma Tbk is a well-known Indonesian pharmaceutical company that has been in the business for over six decades. The company has been consistent in providing healthcare solutions to the Indonesian people. Recently, PT Kimia Farma Tbk released its annual report for the year 2018, which highlights the company’s performance in the previous year.
Overview of the report
The report provides a comprehensive overview of the company’s financial performance, corporate governance, and sustainability efforts. The report is divided into several sections, including a message from the board of directors, a company overview, financial highlights, and sustainability initiatives.
Financial performance
In 2018, PT Kimia Farma Tbk recorded a net income of IDR 4.2 trillion, an increase of 15.4% compared to the previous year. The company’s operating income also increased by 9.9% to IDR 469 billion. The report attributes the growth to increased sales in both the pharmaceutical and medical device segments.
Corporate governance
The company has a strong commitment to corporate governance, which is evident in its policies, practices, and procedures. PT Kimia Farma Tbk has implemented various measures to ensure transparency, accountability, and ethical behavior in its operations. The report also highlights the company’s efforts to improve its risk management framework.
Sustainability initiatives
PT Kimia Farma Tbk is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company has invested in renewable energy sources, improved waste management practices, and implemented green procurement policies. The report also highlights PT Kimia Farma Tbk’s efforts to promote employee well-being and community development.
Conclusion
The annual report for PT Kimia Farma Tbk for the year 2018 provides a comprehensive overview of the company’s performance, governance, and sustainability initiatives. The report highlights the company’s commitment to providing healthcare solutions to the Indonesian people while maintaining ethical and sustainable practices. PT Kimia Farma Tbk’s strong financial performance, commitment to corporate governance, and sustainability initiatives position the company as a leader in the pharmaceutical industry.